CoChat

Stimulation of Healing of Non-Infected Stagnated Diabetic Wounds by Copper Oxide-Impregnated Wound Dressings

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Background and Objective: Copper, a wide spectrum biocide, also plays a key role in angiogenesis and wound healing. Antibacterial wound dressings impregnated with copper oxide microparticles (COD) have been recently cleared by the U.S. FDA and other regulatory bodies for the treatment of acute and chronic wounds, including diabetic wounds. Our objective was to evaluate the capacity of COD in stimulating the healing of non-infected stagnated wounds in diabetic patients initially treated with standard of care (SOC) dressings. Materials and Methods: The trial was divided into the three following phases: 1–2 weeks of screening, during which the patients were treated with SOC dressings; 4 weeks of treatment, during which the COD was applied twice weekly; and 2 weeks of follow-up, during which the patients were again treated with SOC dressings. The wound conditions and sizes were assessed by clinical evaluation and a wound imaging artificial intelligence system. Results: Following 1 month of COD treatment, there was a clear reduction in the mean wound area (53.2%; p = 0.003), an increase in granulation tissue (43.37; p < 0.001), and a reduction in fibrins (47.8%; p = 0.002). In patients with non-weight-bearing wounds, the reduction in wound size was even more dramatic (66.9%; p < 0.001). Conclusions: The results of this study, showing a statistically significant influence of COD on wound healing of hard-to-heal wounds in diabetic patients, strongly supports the notion that copper oxide-impregnated dressings enhance wound healing directly. Further larger controlled studies should be conducted to substantiate our findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/medicina57101129

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The studied copper oxide dressings. The antibacterial wound dressings with copper oxide (COD) are sterile wound dressings composed of an internal absorbent layer and one (left panel) or two (right panel) external nonwoven layers, with or without an adhesive contour. The external layer(s) are made of polypropylene nonwoven fabric, and the internal layer is made of a needle punch layer made of polyester and hydrofibers. The wound dressings achieve at least 800% weight/weight fluid absorbency. Both the internal and external layers are impregnated with copper oxide microparticles. The one or two external layers cover the internal layer from one or both sides, accordingly, and are applied directly to the wound.
Figure 1 The studied copper oxide dressings. The antibacterial wound dressings with copper oxide (COD) are sterile wound dressings composed of an internal absorbent layer and one (left panel) or two (right panel) external nonwoven layers, with or without an adhesive contour. The external layer(s) are made of polypropylene nonwoven fabric, and the internal layer is made of a needle punch layer made of polyester and hydrofibers. The wound dressings achieve at least 800% weight/weight fluid absorbency. Both the internal and external layers are impregnated with copper oxide microparticles. The one or two external layers cover the internal layer from one or both sides, accordingly, and are applied directly to the wound.CC BY · PubMed Central
Figure 2 Study phases and visits to the clinic.
Figure 2 Study phases and visits to the clinic.CC BY · PubMed Central
Figure 3 Repeated-measures ANOVAs of the mean wound size reduction and difference between the WBW and NWBW subgroups during the whole study (a) and during the Treatment Phase only (b).
Figure 3 Repeated-measures ANOVAs of the mean wound size reduction and difference between the WBW and NWBW subgroups during the whole study (a) and during the Treatment Phase only (b).CC BY · PubMed Central
Figure 4 Pictures taken of the wounds throughout the study of 3 representative NWBW subgroups.
Figure 4 Pictures taken of the wounds throughout the study of 3 representative NWBW subgroups.CC BY · PubMed Central
Figure 5 The sizes of the wounds normalized to the initial wound size per wound healing day for all 13 patients are shown. Day 0 represents the day the COD treatment started. Each color represents a different patient. The continuous line represents the Treatment Phase, which is preceded by the Screening Phase (dotted lines) and followed by the Follow-up Phase (dotted lines). The three upper lines belong to the three patients with weight-bearing wounds (WBW) and the other 10 lines belong to the 10 patients with non-weight-bearing wounds (NWBW). Each circle represents the date when the wound dressing was changed in the clinic and the wound size was measured by the wound imaging artificial intelligence system.
Figure 5 The sizes of the wounds normalized to the initial wound size per wound healing day for all 13 patients are shown. Day 0 represents the day the COD treatment started. Each color represents a different patient. The continuous line represents the Treatment Phase, which is preceded by the Screening Phase (dotted lines) and followed by the Follow-up Phase (dotted lines). The three upper lines belong to the three patients with weight-bearing wounds (WBW) and the other 10 lines belong to the 10 patients with non-weight-bearing wounds (NWBW). Each circle represents the date when the wound dressing was changed in the clinic and the wound size was measured by the wound imaging artificial intelligence system.CC BY · PubMed Central
Figure 6 Percentage of wound area during the trial as compared to the wound size at the commencement of the study. The mean ± standard deviation of the wound area of (a) all patients, (b) of those suffering from a non-plantar foot wound, and (c) those suffering from a plantar wound. A paired t-test was conducted between each visit and the next one; * p < 0.05; *** p < 0.001.
Figure 6 Percentage of wound area during the trial as compared to the wound size at the commencement of the study. The mean ± standard deviation of the wound area of (a) all patients, (b) of those suffering from a non-plantar foot wound, and (c) those suffering from a plantar wound. A paired t-test was conducted between each visit and the next one; * p < 0.05; *** p < 0.001.CC BY · PubMed Central
Figure 7 Increase in granulation tissue formation during the Treatment Phase. The mean and SD values of the mean of the granulation scores during each visit are presented. During the Treatment Phase (Visits 2–6), there was a statistically significant increase in the granulation tissue (43.37%; p < 0.001; one-way repeated measures ANOVA). Between Visit 2 and Visit 3, there was a statistically significant increase in the granulation tissue (28.5%; p < 0.01, paired t-test).
Figure 7 Increase in granulation tissue formation during the Treatment Phase. The mean and SD values of the mean of the granulation scores during each visit are presented. During the Treatment Phase (Visits 2–6), there was a statistically significant increase in the granulation tissue (43.37%; p < 0.001; one-way repeated measures ANOVA). Between Visit 2 and Visit 3, there was a statistically significant increase in the granulation tissue (28.5%; p < 0.01, paired t-test).CC BY · PubMed Central
Figure 8 Reduction in fibrin tissue during the Treatment Phase. There was a statistically significant reduction in the percentage of fibrin during Visits 2 to 6 (47.8%; p = 0.002, one-way repeated measures ANOVA).
Figure 8 Reduction in fibrin tissue during the Treatment Phase. There was a statistically significant reduction in the percentage of fibrin during Visits 2 to 6 (47.8%; p = 0.002, one-way repeated measures ANOVA).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 2

  1. Milanino, 2006, Copper in medicine and personal care: A historical overview, N. Y. Inf. Healthc., 1, 149
  2. Shai, A., and Maibach, H.I. (2005). Wound Healing and Ulcers of the Skin, Diagnosis and Therapy-The Practical Approach, Springer.

Cited by

See all 22

Metadata

Authors
Melamed, E., Rovitsky, A., Roth, T., Assa, L., & Borkow, G.
Affiliations
  • Rambam Health Care Campus (IL)
  • MedCu Technologies Ltd., Herzliya 4672200, Israel
Corresponding author
  • Melamed, Eyal
  • Borkow, Gadi
Venue
Medicina
Publisher
MDPI AG
Published
2021-10-19
Volume
57
Issue
10
Pages
1129
ISSN
  • 1010-660X (ISSN-L)
  • 1648-9144
OpenAlex
W3205495960
Cited by
22
References
24
Citations by year
2026: 3 · 2025: 6 · 2024: 8 · 2023: 2 · 2022: 3
FWCI
1.71
Type
journal article
Language
en
Open access
Locations
  • Medicina (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
MedCu Technologies Ltd (010)
Topics
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
  • Health Sciences › Medicine › Surgery › Surgical site infection prevention
Keywords
copper oxide, wound dressings, diabetic wounds, wound healing, granulation tissue, angiogenesis
MeSH terms
Artificial Intelligence, Bandages, Copper, Diabetes Mellitus, Humans, Oxides, Wound Healing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stimulation of Healing of Non-Infected Stagnated Diabetic Wounds by Copper Oxide-Impregnated Wound Dressings. https://app.cochat.ai/papers/10.3390/medicina57101129
The paper
Melamed, E., Rovitsky, A., Roth, T., Assa, L., & Borkow, G. (2021). Stimulation of Healing of Non-Infected Stagnated Diabetic Wounds by Copper Oxide-Impregnated Wound Dressings. Medicina. https://doi.org/10.3390/medicina57101129

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.